Related Experiment Video
Updated: Aug 7, 2026
14:04
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Reversing methicillin resistance in MRSA using a bacterial transforming agent
Bryan E Carey1, Stephanie J Dancer
1Department of Microbiology, Southern General Hospital Glasgow G51 4TF, Scotland, UK.
The Journal of Antimicrobial Chemotherapy
|June 22, 2006
Summary
Bacterial transforming agents (BTAs) show promise in combating methicillin-resistant Staphylococcus aureus (MRSA) infections. This study found that BTA 19976a enhanced the effectiveness of existing antibiotics against MRSA strains in vitro.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Antimicrobial resistance in staphylococci, including MRSA, poses a significant clinical challenge.
- New therapeutic strategies are essential for treating staphylococcal infections.
- Bacterial transforming agents (BTAs) show potential by enhancing the efficacy of existing antibiotics.
Purpose of the Study:
- To evaluate the antimicrobial activity of a specific BTA (BTA 19976a) against MRSA strains in vitro.
- To determine if BTA 19976a can potentiate the effects of established antibiotics against MRSA.
Main Methods:
- Utilized Etest methodology to assess Minimum Inhibitory Concentrations (MICs).
- Employed time-kill assays to evaluate bacterial viability over time.
- Tested BTA 19976a at 10% w/v in combination with methicillin against MRSA strains.
Main Results:
- BTA 19976a reduced oxacillin MICs for multiple MRSA strains.
- Time-kill assays showed reduced viable MRSA counts when treated with methicillin plus BTA compared to methicillin alone.
- Observed strain-specific variations in killing kinetics and regrowth patterns.
Conclusions:
- The observed antimicrobial effects of BTA 19976a against MRSA are promising.
- Further research is warranted, including testing against diverse epidemic strains and comprehensive pharmacokinetic/pharmacodynamic (PK/PD) evaluation.
- This BTA could contribute to the development of novel therapies for staphylococcal infections.
Related Concept Videos
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:33Bacterial Transformation
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
01:33Bacterial Transformation
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
01:26Transformation
Microbial communities are dynamic environments where cell lysis releases free DNA into the surroundings. Other cells can take up this extracellular DNA through a process known as transformation.When a cell incorporates this foreign DNA into its genome, resulting in genetic modification, the process is known as transformation. Cells capable of this process are termed competent. Competence can be natural, as observed in certain bacteria and archaea, or artificially induced in the...
00:57Antibiotic Selection
Overview